Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1379c248137d54bac7307da12986824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3742dd9246a4f1f9fb931c794910288e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba33fe49db4c28493515fa1d8514a274 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f824ff685eab039b312da21dc75a838 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7254887bc4324c447a6a7cfda1e6b29c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a88e6f0fa6aeee94573080148f8abad9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cee5aeade75c4e9e87373ad2c3d7be7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
filingDate |
2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_725d0a62f13726645a20ac024840d75a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02ccfb4c37d69dce8d3402c75199570 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4aabee86b25c57d8d5f0606843e4e45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e1536a348e8fa4942b61c068ff53648 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fee2bdc88ce10ea7b19a2490918fb99 |
publicationDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012081905-A2 |
titleOfInvention |
Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin |
abstract |
Provided is a pharmaceutical composite formulation for preventing or treating cardiovascular diseases, which comprises (1) a first particle comprising an HMG-CoA reductase inhibitor and a basic additive; and (2) a second particle comprising a core containing aspirin and an enteric coating layer coated on said core, wherein the difference in the average diameters of said first and second particles is 100 μm to 800 μm; a method for preparing same; and a method of validating the quality of same. The pharmaceutical composite formulation according to the present invention can improve the stability of an active ingredient and prevent adverse impacts between the active ingredients to thereby enable an accurate quality validation of the pharmaceutical composite formulation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2524645-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014209092-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015526498-A |
priorityDate |
2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |